(Q40424155)
Statements
A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas (English)
Nina Raetzel
Christine Müller
Katharina Kley
Stephan Mathas
Andreas Lietz